|
|
| Line 3: |
Line 3: |
| | <StructureSection load='6otn' size='340' side='right'caption='[[6otn]], [[Resolution|resolution]] 2.40Å' scene=''> | | <StructureSection load='6otn' size='340' side='right'caption='[[6otn]], [[Resolution|resolution]] 2.40Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[6otn]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OTN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6OTN FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6otn]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6OTN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6OTN FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.4Å</td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">TPM3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6otn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6otn OCA], [http://pdbe.org/6otn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6otn RCSB], [http://www.ebi.ac.uk/pdbsum/6otn PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6otn ProSAT]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6otn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6otn OCA], [https://pdbe.org/6otn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6otn RCSB], [https://www.ebi.ac.uk/pdbsum/6otn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6otn ProSAT]</span></td></tr> |
| | </table> | | </table> |
| | == Disease == | | == Disease == |
| - | [[http://www.uniprot.org/uniprot/TPM3_HUMAN TPM3_HUMAN]] Childhood-onset nemaline myopathy;Cap myopathy;Congenital fiber-type disproportion myopathy;Inflammatory myofibroblastic tumor;Intermediate nemaline myopathy;Congenital generalized hypercontractile muscle stiffness syndrome. The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving TPM3 is found in papillary thyroid carcinomas (PTCs). A rearrangement with NTRK1 generates the TRK fusion transcript by fusing the amino end of isoform 2 of TPM3 to the 3'-end of NTRK1.<ref>PMID:2869410</ref> The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. | + | [https://www.uniprot.org/uniprot/TPM3_HUMAN TPM3_HUMAN] Childhood-onset nemaline myopathy;Cap myopathy;Congenital fiber-type disproportion myopathy;Inflammatory myofibroblastic tumor;Intermediate nemaline myopathy;Congenital generalized hypercontractile muscle stiffness syndrome. The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving TPM3 is found in papillary thyroid carcinomas (PTCs). A rearrangement with NTRK1 generates the TRK fusion transcript by fusing the amino end of isoform 2 of TPM3 to the 3'-end of NTRK1.<ref>PMID:2869410</ref> The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry. |
| | == Function == | | == Function == |
| - | [[http://www.uniprot.org/uniprot/TPM3_HUMAN TPM3_HUMAN]] Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.[UniProtKB:P09493] | + | [https://www.uniprot.org/uniprot/TPM3_HUMAN TPM3_HUMAN] Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.[UniProtKB:P09493] |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 21: |
Line 21: |
| | </div> | | </div> |
| | <div class="pdbe-citations 6otn" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 6otn" style="background-color:#fffaf0;"></div> |
| | + | |
| | + | ==See Also== |
| | + | *[[Tropomyosin|Tropomyosin]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| - | [[Category: Human]] | + | [[Category: Homo sapiens]] |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Ghosh, A]] | + | [[Category: Ghosh A]] |
| - | [[Category: Gunning, P W]] | + | [[Category: Gunning PW]] |
| - | [[Category: Janco, M]] | + | [[Category: Janco M]] |
| - | [[Category: Lehman, W J]] | + | [[Category: Lehman WJ]] |
| - | [[Category: Rynkiewicz, M J]] | + | [[Category: Rynkiewicz MJ]] |
| - | [[Category: Coiled coil]]
| + | |
| - | [[Category: Fragment]]
| + | |
| - | [[Category: Structural protein]]
| + | |
| - | [[Category: Tropomyosin]]
| + | |
| Structural highlights
Disease
TPM3_HUMAN Childhood-onset nemaline myopathy;Cap myopathy;Congenital fiber-type disproportion myopathy;Inflammatory myofibroblastic tumor;Intermediate nemaline myopathy;Congenital generalized hypercontractile muscle stiffness syndrome. The disease is caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving TPM3 is found in papillary thyroid carcinomas (PTCs). A rearrangement with NTRK1 generates the TRK fusion transcript by fusing the amino end of isoform 2 of TPM3 to the 3'-end of NTRK1.[1] The disease is caused by mutations affecting the gene represented in this entry. The disease is caused by mutations affecting the gene represented in this entry.
Function
TPM3_HUMAN Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.[UniProtKB:P09493]
Publication Abstract from PubMed
Tropomyosins (Tpm) determine the functional capacity of actin filaments in an isoform-specific manner. The primary isoform in cancer cells is Tpm3.1 and compounds that target Tpm3.1 show promising results as anti-cancer agents both in vivo and in vitro. We have determined the molecular mechanism of interaction of the lead compound ATM-3507 with Tpm3.1-containing actin filaments. When present during co-polymerization of Tpm3.1 with actin, (3)H-ATM-3507 is incorporated into the filaments and saturates at approximately one molecule per Tpm3.1 dimer and with an apparent binding affinity of approximately 2 microM. In contrast, (3)H-ATM-3507 is poorly incorporated into preformed Tpm3.1/actin co-polymers. CD spectroscopy and thermal melts using Tpm3.1 peptides containing the C-terminus, the N-terminus, and a combination of the two forming the overlap junction at the interface of adjacent Tpm3.1 dimers, show that ATM-3507 shifts the melting temperature of the C-terminus and the overlap junction, but not the N-terminus. Molecular dynamic simulation (MDS) analysis predicts that ATM-3507 integrates into the 4-helix coiled coil overlap junction and in doing so, likely changes the lateral movement of Tpm3.1 across the actin surface resulting in an alteration of filament interactions with actin binding proteins and myosin motors, consistent with the cellular impact of ATM-3507.
Molecular integration of the anti-tropomyosin compound ATM-3507 into the coiled coil overlap region of the cancer-associated Tpm3.1.,Janco M, Rynkiewicz MJ, Li L, Hook J, Eiffe E, Ghosh A, Bocking T, Lehman WJ, Hardeman EC, Gunning PW Sci Rep. 2019 Aug 2;9(1):11262. doi: 10.1038/s41598-019-47592-9. PMID:31375704[2]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Martin-Zanca D, Hughes SH, Barbacid M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature. 1986 Feb 27-Mar 5;319(6056):743-8. PMID:2869410 doi:http://dx.doi.org/10.1038/319743a0
- ↑ Janco M, Rynkiewicz MJ, Li L, Hook J, Eiffe E, Ghosh A, Bocking T, Lehman WJ, Hardeman EC, Gunning PW. Molecular integration of the anti-tropomyosin compound ATM-3507 into the coiled coil overlap region of the cancer-associated Tpm3.1. Sci Rep. 2019 Aug 2;9(1):11262. doi: 10.1038/s41598-019-47592-9. PMID:31375704 doi:http://dx.doi.org/10.1038/s41598-019-47592-9
|
